7JPL
Rabbit Cav1.1 in the presence of 10 micromolar (S)-(-)-Bay K8644 in nanodiscs at 3.4 Angstrom resolution
7JPL の概要
エントリーDOI | 10.2210/pdb7jpl/pdb |
EMDBエントリー | 22414 22415 22424 22425 22426 |
分子名称 | Voltage-dependent L-type calcium channel subunit alpha-1S, Voltage-dependent calcium channel gamma-1 subunit, Voltage-dependent calcium channel subunit alpha-2/delta-1, ... (7 entities in total) |
機能のキーワード | rcav1.1, channels, calcium ion-selective, transport protein, drugs |
由来する生物種 | Oryctolagus cuniculus (Rabbit) 詳細 |
タンパク質・核酸の鎖数 | 3 |
化学式量合計 | 370324.86 |
構造登録者 | |
主引用文献 | Gao, S.,Yan, N. Structural Basis of the Modulation of the Voltage-Gated Calcium Ion Channel Ca v 1.1 by Dihydropyridine Compounds*. Angew.Chem.Int.Ed.Engl., 60:3131-3137, 2021 Cited by PubMed Abstract: 1,4-Dihydropyridines (DHP), the most commonly used antihypertensives, function by inhibiting the L-type voltage-gated Ca (Ca ) channels. DHP compounds exhibit chirality-specific antagonistic or agonistic effects. The structure of rabbit Ca 1.1 bound to an achiral drug nifedipine reveals the general binding mode for DHP drugs, but the molecular basis for chiral specificity remained elusive. Herein, we report five cryo-EM structures of nanodisc-embedded Ca 1.1 in the presence of the bestselling drug amlodipine, a DHP antagonist (R)-(+)-Bay K8644, and a titration of its agonistic enantiomer (S)-(-)-Bay K8644 at resolutions of 2.9-3.4 Å. The amlodipine-bound structure reveals the molecular basis for the high efficacy of the drug. All structures with the addition of the Bay K8644 enantiomers exhibit similar inactivated conformations, suggesting that (S)-(-)-Bay K8644, when acting as an agonist, is insufficient to lock the activated state of the channel for a prolonged duration. PubMed: 33125829DOI: 10.1002/anie.202011793 主引用文献が同じPDBエントリー |
実験手法 | ELECTRON MICROSCOPY (3.4 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード